Disc Medicine target price raised to $130 from $100
IRON•Leerink Partners raised its target price for Disc Medicine to $130 from $100.
Related News
Stocks, bonds edge up ahead of 'formidable' week for risk
SPY•
Volkswagen partners with NXP on chips for software-defined vehicles
NXPI•
PowerBank completes CAD 25.4 million solar project refinancing with major Canadian bank
SUUN•
Inomin Mines extends Onuki discovery footprint to 900 meters at Beaver-Lynx project
IMC•
TuHURA reports partial responses in first three patients in IFx-2.0–Keytruda trial
HURA•